Evidence map›Paper›PMID 37289061›Full record

ArticleMicrobiology spectrum2023

Scott A Cunningham, Christophe Rodriguez, Paul-Louis Woerther, Christophe Menigaux, Thomas Bauer, Jean-Louis Herrmann, Martin Rottman, Anne-Laure Roux, Jean-Louis Gaillard, Robin Patel and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Bacterial skin colonization with a specificMicrobiology spectrum · 2025
    Article
  2. Microorganisms · 2024
    Article
  3. First case ofHeliyon · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Scott A CunninghamDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Christophe RodriguezNGS Platform, IMRB, CHU Henri Mondor, Créteil, France.
Paul-Louis WoertherNGS Platform, IMRB, CHU Henri Mondor, Créteil, France.ORCID 0000-0002-6957-9482
Christophe MenigauxAPHP, GHU Paris Saclay, Hôpital Ambroise Paré, Orthopedic Surgery Department, Boulogne-Billancourt, France.
Thomas BauerAPHP, GHU Paris Saclay, Hôpital Ambroise Paré, Orthopedic Surgery Department, Boulogne-Billancourt, France.
Jean-Louis HerrmannAPHP, GHU Paris Saclay, Hôpital Raymond Poincaré, Microbiology Department, Garches, France.
Martin RottmanAPHP, GHU Paris Saclay, Hôpital Raymond Poincaré, Microbiology Department, Garches, France.ORCID 0000-0001-5953-3344
Anne-Laure RouxUniversité Paris-Saclay, UVSQ, Inserm, Infection et Inflammation, Montigny-Le-Bretonneux, France.
Jean-Louis GaillardUniversité Paris-Saclay, UVSQ, Inserm, Infection et Inflammation, Montigny-Le-Bretonneux, France.
Robin PatelDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0001-6344-4141
Faten El SayedUniversité Paris-Saclay, UVSQ, Inserm, Infection et Inflammation, Montigny-Le-Bretonneux, France.ORCID 0000-0002-1308-2389
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRMayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutibacterium avidum is an emerging causative agent of orthopedic device-related infections (ODRIs). There are no guidelines for the antimicrobial treatment of

Indexed as

LevofloxacinPropionibacteriaceaeAnti-Bacterial AgentsFluoroquinolonesHumansMicrobial Sensitivity TestsRifampinAnti-Bacterial AgentsFluoroquinolonesLevofloxacinRifampinantibiotic resistancebone and joint infectionsCutibacterium avidumin vivo emergence of resistancemechanisms of resistanceosteoarticular infection

Identifiers

PMID37289061
PMCPMC10434181
OpenAlexW4379768285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.